Cargando…
Successful Management of Clozapine-induced Akathisia with Gabapentin Enacarbil: A Case Report
The management of clozapine (CLZ)-induced adverse events affects patient prognoses. Akathisia is a relatively rare adverse event related to CLZ administration and thus the management of this syndrome is not well established. Here, we report a case of treatment-resistant schizophrenia wherein CLZ-ind...
Autores principales: | Takeshima, Masahiro, Ishikawa, Hiroyasu, Kikuchi, Yuka, Kanbayashi, Takashi, Shimizu, Tetsuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean College of Neuropsychopharmacology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124867/ https://www.ncbi.nlm.nih.gov/pubmed/30121987 http://dx.doi.org/10.9758/cpn.2018.16.3.346 |
Ejemplares similares
-
Gabapentin enacarbil for antipsychotic induced akathisia in schizophrenia patients: a pilot open-labeled study
por: Takeshima, Masahiro, et al.
Publicado: (2018) -
A Comment on “Successful Management of Clozapine-induced Akathisia with Gabapentin Enacarbil: A Case Report”
por: Naguy, Ahmed
Publicado: (2019) -
Relationship between Clozapine-Induced Electroencephalogram Abnormalities and Serum Concentration of Clozapine in Japanese Patients with Treatment-Resistant Schizophrenia
por: Kikuchi, Yuka Sugawara, et al.
Publicado: (2019) -
Gabapentin Enacarbil: Pharmacotherapy of Restless Legs Syndrome
por: Jones, Ruth, et al.
Publicado: (2010) -
Gabapentin enacarbil – clinical efficacy in restless legs syndrome
por: Agarwal, Pinky, et al.
Publicado: (2010)